Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine infusion for postoperative pain and opioid reduction after laparotomy
IRCT20240619062178N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lidocaine in postoperative pain, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Postoperative pain intensity and Postoperative opioid consumption. Started Jul 2024; status: completed.
02
Drugs
lidocaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20240619062178N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240619062178N1.